No profile data available.
XBiotech Inc. (XBIT) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Austin, United States, with about 87 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$45.54 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $0. Its market capitalization was $69.82 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases.
XBiotech reported $0 in revenue for fiscal year 2025. In Q1 2026 revenue was $0.
$69.82 million as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Vivani Medical, Inc. (VANI), Revium Rx (RVRC), Telomir Pharmaceuticals, Inc. (TELO), Metagenomi, Inc. (MGX).